Tahoe Therapeutics is building AI-powered models of the human cell to design better drugs for more patients. Its technology platform generates large-scale, perturbative single-cell datasets that enable a new generation of biological foundation models. Based in South San Francisco, Tahoe was founded by a team of scientists and technologists advancing the frontiers of drug discovery, genomics, and machine learning.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/11/25 | $30,000,000 | Venture |
AIX Ventures Amplify Partners  Civilization Ventures Conviction Capital Databricks Ventures General Catalyst Mubadala Capital Wing Ventures | undisclosed |
